Several intervention strategies were designed to affect HGF/c-Met signaling: inhibitors of HGF activation, HGF neutralizing antibodies Rilotumumab (AMG102), Ficlatuzumab (AV-299) and TAK701 [61], c-Met antagonists Onartuzumab, CE-355621, selective inhibitors of c-Met kinase activity Tivantinib, AMG-337, AMG-458, Foretinib, PHA-665725, MK-2461, PF-04217903 and SU11274, and nonselective multitarget inhibitors of RTK including c-Met such as Crizotinib and Cabozantinib
Pair waxing with a dedicated tan removal routine for best results
This series of 10 treatments can typically lighten skin from one to two shades
Restivo pays attention to detail and delivers great results! -J
The only meaningful lab consideration is copper status , and only for users running continuous high-dose (23 mg/day SC) systemic GHK-Cu beyond ~6 months: Serum copper and ceruloplasmin once at baseline before a long systemic run, once at the 6-month mark